In the final chapter of the PRS series, learn more about future uses for polygenic risk scores, from stratifying populations and targeting high-risk individuals to early intervention and preventative medicine. Industry experts from the University of Queensland, Genome Analytics Japan, King’s College, and the Bio-X Institute at Shanghai Jiao Tong University share their visions for the future.<br>

View related article: Polygenic Risk Scores Could Become Useful Tools in the Physician's Toolbox

<a href="/content/illumina-marketing/en/science/customer-stories/icommunity-customer-interviews-case-studies/queensland-interview-prs-gsa.html">Read Article</a><br>

Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc<br>

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.<br>

*Data calculations on file. Illumina, Inc., 2015.<br>

View customer spotlight videos

https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79<br>

View Illumina webinars

https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ<br>

View Illumina product videos

https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd<br>

View Illumina support videos

https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM<br>